Literature DB >> 11269484

Surgical treatment of hepatic and pulmonary metastases from colon cancer.

J R Headrick1, D L Miller, D M Nagorney, M S Allen, C Deschamps, V F Trastek, P C Pairolero.   

Abstract

BACKGROUND: Surgical resection of isolated hepatic or pulmonary metastases secondary to colorectal cancer has been shown to yield acceptable long-term survival. However, results are inconclusive for surgical resection of both hepatic and pulmonary metastases.
METHODS: We reviewed the records of all patients who underwent surgical resection of both hepatic and pulmonary metastases from colorectal cancer between 1980 and 1998.
RESULTS: A total of 58 patients underwent resection of both hepatic and pulmonary metastases secondary to colorectal cancer. All patients had local control of their primary cancer before metastasectomy. There were no operative deaths. Morbidity occurred in 12% of patients. Follow-up was complete in all patients, with a median duration of 62 months (range, 6 to 201 months). The 5- and 10-year survivals were 30% and 16%, respectively. A premetastasectomy carcinoembryonic antigen level greater than 5 ng/mL increased the risk of early death (p = 0.029). Neither the number of pulmonary lesions nor the time interval between the primary surgery and the metastasectomy had a significant impact on survival (p = 0.67). At 5 years, 55% of patients were free of disease. Four patients had lymph node involvement at the time of pulmonary resection and all 4 patients died within 22 months of their pulmonary metastasectomy.
CONCLUSIONS: Resection of both hepatic and pulmonary metastases secondary to colorectal cancer in highly selected patients is safe and results in long-term survival. Thoracic lymph node involvement and elevated carcinoembryonic antigen levels before pulmonary metastasectomy are associated with reduced survival.

Entities:  

Mesh:

Year:  2001        PMID: 11269484     DOI: 10.1016/s0003-4975(00)02522-4

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  56 in total

1.  Radiofrequency ablation for colorectal liver metastases: prognostic factors in non-surgical candidates.

Authors:  Ayumi Hamada; Koichiro Yamakado; Atsuhiro Nakatsuka; Junji Uraki; Masataka Kashima; Haruyuki Takaki; Takashi Yamanaka; Yasuhiro Inoue; Masato Kusunoki; Kan Takeda
Journal:  Jpn J Radiol       Date:  2012-06-05       Impact factor: 2.374

2.  Survival after lung metastasectomy in colorectal cancer patients with previously resected liver metastases.

Authors:  Michel Gonzalez; John Henri Robert; Nermin Halkic; Gilles Mentha; Arnaud Roth; Thomas Perneger; Hans Beat Ris; Pascal Gervaz
Journal:  World J Surg       Date:  2012-02       Impact factor: 3.352

3.  Optimal use of current chemotherapy in multimodality therapy for advanced colorectal cancer.

Authors:  Yasuhiro Inoue; Junichiro Hiro; Yuji Toiyama; Koji Tanaka; Yasuhiko Mohri; Masato Kusunoki
Journal:  Oncol Lett       Date:  2011-12-01       Impact factor: 2.967

4.  Guidelines for resection of colorectal cancer liver metastases.

Authors:  O J Garden; M Rees; G J Poston; D Mirza; M Saunders; J Ledermann; J N Primrose; R W Parks
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

5.  Accuracy of transmission CT and FDG-PET in the detection of small pulmonary nodules with integrated PET/CT.

Authors:  Suzanne L Aquino; Landon B Kuester; Victorine V Muse; Elkan F Halpern; Alan J Fischman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-03-03       Impact factor: 9.236

6.  Simultaneous lung resection via a transdiaphragmatic approach in patients undergoing liver resection for synchronous liver and lung metastases.

Authors:  Yoshihiro Mise; Reza J Mehran; Thomas A Aloia; Jean-Nicolas Vauthey
Journal:  Surgery       Date:  2014-06-20       Impact factor: 3.982

7.  Trends in the treatment outcomes for advanced colorectal cancer: an analysis at a single community hospital in Japan.

Authors:  Morimasa Tomikawa; Daisuke Korenaga; Tomohiko Akahoshi; Kenichi Kohshi; Keishi Sugimachi; Yasuharu Ikeda; Kenji Takenaka; Yoshihiko Maehara
Journal:  Surg Today       Date:  2011-05-28       Impact factor: 2.549

8.  Pulmonary resection for isolated pancreatic adenocarcinoma metastasis: an analysis of outcomes and survival.

Authors:  George J Arnaoutakis; Deepa Rangachari; Daniel A Laheru; Chris A Iacobuzio-Donahue; Ralph H Hruban; Joseph M Herman; Barish H Edil; Timothy M Pawlik; Richard D Schulick; John L Cameron; Avedis Meneshian; Stephen C Yang; Christopher L Wolfgang
Journal:  J Gastrointest Surg       Date:  2011-07-02       Impact factor: 3.452

9.  Aggressive surgical resection for concomitant liver and lung metastasis in colorectal cancer.

Authors:  Sung Hwan Lee; Sung Hyun Kim; Jin Hong Lim; Sung Hoon Kim; Jin Gu Lee; Dae Joon Kim; Gi Hong Choi; Jin Sub Choi; Kyung Sik Kim
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2016-08-29

10.  Sequential surgical resection of hepatic and pulmonary metastases from colorectal cancer.

Authors:  Stefan Limmer; Elisabeth Oevermann; Claudia Killaitis; Peter Kujath; Martin Hoffmann; Hans-Peter Bruch
Journal:  Langenbecks Arch Surg       Date:  2010-02-18       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.